{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:05:25Z","timestamp":1774451125450,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ejphar.2008.06.006","type":"journal-article","created":{"date-parts":[[2008,6,8]],"date-time":"2008-06-08T04:12:34Z","timestamp":1212898354000},"page":"322-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat"],"prefix":"10.1016","volume":"590","author":[{"given":"Sotiria","family":"Bexis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Aiden","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.06.006_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.bjp.0701444","article-title":"Vascular actions of octreotide in the portal hypertensive rat","volume":"122","author":"Aboud","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0016-5085(93)90429-G","article-title":"Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats","volume":"104","author":"Albillos","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00042728-200504000-00002","article-title":"Laser-Doppler examination shows high flow in some common telangiectasias of the lower limb","volume":"31","author":"Bihari","year":"2005","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ejphar.2008.06.006_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1098-8823(03)00080-7","article-title":"Eicosanoids in cirrhosis and portal hypertension","volume":"72","author":"Birney","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2008.06.006_bib5","first-page":"148","article-title":"Pharmacological therapy for portal hypertension: rationale and results","volume":"6","author":"Burroughs","year":"1995","journal-title":"Semin. Gastrointest. Dis."},{"key":"10.1016\/j.ejphar.2008.06.006_bib6","first-page":"516","article-title":"Kuang Y. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats","volume":"112","author":"Cao","year":"1999","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejphar.2008.06.006_bib7","first-page":"564","article-title":"Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Hepatobiliary Pancreat","volume":"5","author":"Cao","year":"2006","journal-title":"Dis. Int."},{"key":"10.1016\/j.ejphar.2008.06.006_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000139350","article-title":"Investigations of the function of the vascular endothelium in portal hypertensive rats","volume":"51","author":"Cawley","year":"1995","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1476-5381.1995.tb13274.x","article-title":"Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta","volume":"114","author":"Cawley","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib10","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.juro.2007.07.122","article-title":"Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in rats","volume":"178","author":"Cefalu","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.510300317","article-title":"Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin","volume":"30","author":"Chan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/jhep.2001.23079","article-title":"Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats","volume":"33","author":"Chan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2362.2004.01336.x","article-title":"Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats","volume":"34","author":"Chan","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2008.06.006_bib14","first-page":"203","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: what's new?","volume":"70","author":"Colle","year":"2007","journal-title":"Acta Gastroenterol. Belg."},{"key":"10.1016\/j.ejphar.2008.06.006_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1053\/gast.1996.v110.pm8613060","article-title":"Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis","volume":"110","author":"Fern\u00e1ndez","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1113\/jphysiol.1990.sp018354","article-title":"Responses of bone and joint blood vessels in cats and rabbits to electrical stimulation of nerves supplying the knee","volume":"431","author":"Ferrell","year":"1990","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.510270105","article-title":"Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation","volume":"27","author":"Hou","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2362.2003.01162.x","article-title":"Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats","volume":"33","author":"Huang","year":"2003","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2008.06.006_bib19","first-page":"279","article-title":"The effect of prostacyclin on the gastric mucosa in portal-hypertensive rats","volume":"49","author":"Kishihara","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib20","first-page":"G322","article-title":"Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats","volume":"254","author":"Kravetz","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib22","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3748\/wjg.v12.i15.2351","article-title":"Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin","volume":"12","author":"Lay","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib23","first-page":"489","article-title":"Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension","volume":"2","author":"McCormick","year":"1990","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib24","first-page":"839","article-title":"The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension","volume":"5","author":"McCormick","year":"1993","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-8278(05)80516-1","article-title":"Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide","volume":"17","author":"McCormick","year":"1993","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/hep.1840210507","article-title":"Cardiovascular effects of octreotide in patients with hepatic cirrhosis","volume":"21","author":"McCormick","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2680.1998.1860357.x","article-title":"Cardiovascular actions of nitric oxide synthase inhibition in the portal hypertensive rat","volume":"18","author":"McDaid","year":"1998","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hep.1840180322","article-title":"Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension","volume":"18","author":"Oberti","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0952-3278(95)90081-0","article-title":"Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy","volume":"53","author":"Ohta","year":"1995","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ejphar.2008.06.006_bib30","first-page":"G618","article-title":"Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model","volume":"248","author":"Sikuler","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199303000-00006","article-title":"Effect of portosystemic shunting on PGI2 and glucagon levels in humans","volume":"217","author":"Sitzmann","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejphar.2008.06.006_bib32","first-page":"290","article-title":"Prostacyclin production in acute, chronic, and long-term experimental portal hypertension","volume":"115","author":"Sitzmann","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.ejphar.2008.06.006_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/nau.10034","article-title":"Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats","volume":"21","author":"Takeda","year":"2002","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2008.06.006_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1440-1746.1999.01930.x","article-title":"A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury","volume":"14","author":"Tsugawa","year":"1999","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2008.06.006_bib35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.1840180621","article-title":"Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension","volume":"18","author":"Wu","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.06.006_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3748\/wjg.v11.i5.752","article-title":"Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats","volume":"11","author":"Wu","year":"2005","journal-title":"World J. Gastroenterol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:30Z","timestamp":1757974170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908006171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":36,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0014299908006171"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}